Clinic
Dhew Ind HLTH SV HLTH Svs&mntal HLTH Adm
Dhew Ind HLTH SV HLTH Svs&mntal HLTH Adm was paid $3.71M by Medicaid between Jan 2018 and Oct 2023, across 54 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoDHEW IND HLTH SV HLTH SVS&MNTAL HLTH ADM
FORT DUCHESNE, UT 84026
FORT DUCHESNE, UT 84026
33aNPI1508887993assigned 07/21/2006
33bProvider typeFederal Public Health Clinic/Center
28Total paid$3.71M
24GClaims23,931
24DCodes billed54
24AFirst – last monthJan 2018 – Oct 2023
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,884 | $382K | |
| 2019 | 3,163 | $400K | |
| 2020 | 5,204 | $676K | |
| 2021 | 6,138 | $984K | |
| 2022 | 6,496 | $1.26M | |
| 2023 | 46 | $11K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 2,958 | 2,650 | $1.21M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 1,488 | 1,411 | $622K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9.3% | 737 | 677 | $344K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 9.1% | 806 | 728 | $339K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.8% | 1,351 | 1,250 | $329K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3.5% | 305 | 283 | $132K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.4% | 1,147 | 1,138 | $126K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 1,976 | 1,897 | $72K |
| 90686 | 1.7% | 598 | 596 | $64K | |
| D0140 | Limited oral evaluation - problem focused | 1.6% | 201 | 186 | $60K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.4% | 109 | 95 | $52K |
| 99442 | 1.3% | 134 | 129 | $49K |
42 more codes
| 99441 | 1.0% | 105 | $38K | |
| D0220 | Intraoral - periapical first radiographic image | 1.0% | 199 | $38K |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 2,376 | $37K |
| 80061 | Lipid panel | <1% | 705 | $31K |
| 99443 | <1% | 62 | $22K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,899 | $21K |
| 81003 | <1% | 1,540 | $16K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 39 | $15K |
| 0011A | <1% | 31 | $14K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 130 | $13K |
| D9215 | <1% | 74 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,731 | $8K |
| 0003A | <1% | 13 | $8K | |
| 0064A | <1% | 18 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 755 | $6K |
| 92015 | Determination of refractive state | <1% | 238 | $4K |
| 0134A | <1% | 33 | $3K | |
| 90651 | <1% | 44 | $3K | |
| 82043 | <1% | 522 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $3K |
| 80305 | <1% | 31 | $3K | |
| 92002 | <1% | 27 | $3K | |
| D0330 | Panoramic radiographic image | <1% | 12 | $2K |
| 90734 | <1% | 36 | $1K | |
| 0124A | <1% | 23 | $1K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 88 | $882.00 |
| 87210 | <1% | 13 | $640.00 | |
| D1330 | <1% | 50 | $479.00 | |
| 90688 | <1% | 45 | $427.00 | |
| 83721 | <1% | 519 | $39.48 | |
| 82570 | 0% | 30 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 218 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 109 | $0.00 |
| 81025 | 0% | 80 | $0.00 | |
| 86709 | 0% | 12 | $0.00 | |
| D0460 | 0% | 17 | $0.00 | |
| 87340 | 0% | 13 | $0.00 | |
| 87486 | 0% | 109 | $0.00 | |
| 87581 | 0% | 109 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 12 | $0.00 |
| 83986 | 0% | 30 | $0.00 | |
| 86706 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARTIN, DELBERT (CHIEF PHARMACIST)